Back to News
Market Impact: 0.35

Stocks making the biggest moves midday: Nvidia, Okta, Hormel, Veeva, HP, Celsius, Best Buy & more

Source: CNBC

+9
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesMarket Technicals & FlowsCompany Fundamentals
Stocks making the biggest moves midday: Nvidia, Okta, Hormel, Veeva, HP, Celsius, Best Buy & more

Midday stock moves were driven mainly by earnings beats/misses and guidance updates: Nvidia surged 9% after Q2 revenue more than doubled to $96.22B and EPS beat to $2.22 vs $2.10 consensus, with Q3 revenue guided to $108B. On the upside, Veeva jumped 16%, Salesforce rose 21% on adjusted EPS of $5.90 vs $3.27 estimate, and Okta gained >27% after beating both $1.05 EPS and $805M revenue and raising full-year guidance; CrowdStrike climbed ~19%. Offsetting declines included Wendy’s down 13% after Trian Fund said it won’t pursue a buy, while HP fell 4% (chip-cost and demand concerns) and Moderna dropped 4% on a proposed $2B convertible note private placement.

Analysis

The cleanest signal is not “beats matter,” it’s that the market is rewarding credible margin and guide inflections while punishing anything that looks like cost inflation or delayed recovery. NVDA’s print should have a second-order effect across the AI stack over the next 1-3 months: stronger capex confidence tends to unlock adjacent enterprise software and security budgets, which is why CRM, CRWD, OKTA, and VEEV can keep rerating even if their own prints were already good. The risk is positioning—if hyperscaler spend commentary cools or export policy tightens, the AI multiple reset can be fast and violent.

On the consumer side, the tape is drawing a sharp line between names with pricing power and those with only traffic. DG is the clearest trade-down beneficiary because buybacks plus raised guidance usually compress the quality gap versus DLTR/BURL, where margin pressure is the real story, not just demand. HPQ is more interesting as a margin canary: memory inflation is a delayed earnings headwind that can spill into OEM pricing discipline and refresh demand over the next 1-2 quarters.

Contrarian view: the consensus may be over-focusing on the size of the initial price reactions and underestimating duration. The software/security group could have a longer runway than the one-day move implies if enterprise budget release is real, while the retail losers may already be reflecting a more fragile consumer than the street is modeling. For now, the strongest conviction is relative value, not outright beta.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.05

Ticker Sentiment

BBY0.15
BURL-0.45
CELH-0.55
CRM0.60
CRWD0.50
DG0.40
DLTR-0.20
HPQ-0.25
MRNA-0.70
NVDA0.80
OKTA0.60
VEEV0.50
WEN-0.60

Key Decisions for Investors

  • Long CRM/CRWD basket on a 1-2 week consolidation, 3-6 month horizon: use equal-weight exposure to express that enterprise software/security is now getting funded by the same AI capex optimism that drove NVDA. Falsify if next-quarter billings/guidance fail to improve or if the post-earnings gap fills.
  • Pair trade: long DG / short DLTR for 1-3 months. DG looks like the better trade-down beneficiary with buyback support, while DLTR still faces second-half margin pressure. Cover the short if DLTR guides back up or if DG comps decelerate materially.
  • Short HPQ on rallies or buy a 2-3 month put spread: margin compression from memory costs is the cleaner thesis than top-line growth. Risk is limited if HPQ proves it can pass through costs without volume loss; use next-quarter gross margin as the stop.
  • Short CELH tactically on strength over the next 4-8 weeks: the downgrade suggests the recovery narrative has been pushed out, so any bounce is likely to be sold until there is hard evidence of reacceleration. Falsify if channel checks show meaningful share stabilization before FY27.

More News

From AllMind Research

Browse all research